Newfound Research’s Cognex CGNX Stock Holding History

Newfound Research’s Portfolio CGNX Stock Details CGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-501	Closed	-$42K	–	123
2021 Q2	$42K	Buy	+501	New	+$40.5K	0.08%	114

Other funds holding CGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Newfound Research's CGNX Position: Q3 2021 in Review

Newfound Research sold out of Cognex (CGNX) in Q3 2021, closing a stake of 501 shares — an estimated $42K sold.

Newfound Research first reported a position in CGNX in Q2 2021 and held it in 1 quarter. The position peaked at $42K in Q2 2021. 534 funds tracked by Wall St. Rank hold CGNX as of Q3 2021.

Newfound Research reported no remaining Cognex position as of Q3 2021 after selling out during the quarter.
Newfound Research sold 501 Cognex shares in Q3 2021, an estimated $42K.
Newfound Research first reported a position in Cognex in Q2 2021 and held it in 1 quarter.
Newfound Research's Cognex position peaked at $42K in Q2 2021.
534 funds tracked by Wall St. Rank held Cognex as of Q3 2021.

Based on Newfound Research's 13F filing for Q3 2021, filed 14 Oct 2021.